INTRODUCTION
The y-chains of human fetal hemoglobin (Hb-F)l are produced by nonallelic genes (1, 2) . Evidence for this is derived from the observation that Hb-F contains two types of y-chains; namely, one with glycine in position 136 (the Gy_chain) and a second with alanine in this position (the Ayy-chain). The recent discovery of the Ty-chain by Ricco et al. (3) has added yet another facet to the many ways in which the study of Hb-F has provided data about the genetics ofthis fetal protein. In the Ty-chain, the isoleucyl residue at position 75 of the y-chain is replaced by a threonyl residue. Although Ricco et al. (3) particularly examined the frequency of the Ty-chain in f8-thalassemia, they also detected its presence in cord bloods. Our studies of the T y-chain (4) substantiated their data in f8-thalassemia of individuals of Mediterranean origin, but detected no T-y-chains in the ,8-thalassemia of Blacks. Moreover, our data from cord blood suggested that the frequency of the Tyy-chain might be related to ethnic source or geographical locality, and quantitatively was present in greater percentage than reported by Ricco et al. Because of the limited data, conclusions could only be tentative, and statistical evaluation had limited meaning. Consequently, we have extended these studies in several areas and examined other previously unstudied abnormalities.
METHODS
Many samples of Hb-F were available from previous investigations of the Gy_ to Ay-ratio in Hb-F (1, 2) . In most of these, not only y-and a-chains, but considerable percentages of (3-chains were also present. For most samples, the Gy-to Ay-ratio was known as well as the percentages of Hb-F and Hb-A2; procedures for these determinations have been described in detail (1, 2) .
The methods oftryptic hydrolysis, column chromatographic isolation of the yT-9 peptides (residues 67-76, inclusive), their amino-acid analysis, and the calculation of results have been described in detail (4) and were used without major modification. To assess the reproducibility of results within and between laboratories in Pasadena, Calif. and Augusta, In these experiments, the peptides TyT-9 and 'yT-9 were isolated in Pasadena, Calif., but portions were analyzed both in Pasadena, Calif. and Augusta, Ga. * Data from Pasadena, Calif.
4 Data from Augusta, Ga. gested that technical problems existed in addition to the use of the one-column system (4). The remaining data reveal that duplicate determinations may be expected to agree within +3%. This degree of concordance between duplicate determinations is somewhat unexpected, because neither of the yT-9 peptides is pure as isolated, and the interpretation of the amino-acid analyses is subjective to a degree.
RESULTS
The T-chain in cord bloods. Table II summarizes the results from the examination for Ty-chains in cord bloods from a variety of ethnic and geographic sources. These data include the information previously reported (4). Initially, Hb-F from 98 newborn was studied; to these data may now be added the results from 96 samples. Two other ethnic groups, Kenya Blacks and Asiatic Indians, have been examined in these additional samples; positive samples were detected in both.
Of the original 98 samples, 70 were negative. Consequently, the frequency of the Tyy-gene in this group was 0.14. There are 149 negative results in the present 194 so that the Ty-frequency (0.12) is about the same. It is noteworthy that Blacks as well as Caucasians from several geographic areas had positive samples in frequencies that probably were not greatly different from each other.
The distribution of positive data in terms of the percentage of Ty-chain is presented in Fig. 1 . Two groups were observed: One group of four averaged 31% Tychain, and the remaining 39 averaged 18% (17% for 23 Black babies and 19% for 16 Caucasian newbom). 10 Veddoid Indians, and 1 Israeli citizen) has been examined; 7 from Blacks and 0 from Veddoid Indians were positive for the Ty-chain (Tables II and  III ). All information on the seven positive cases is detailed in Table IV (Table V) . These results do not exclude the presence of a Ty-gene in trans to the HPFH determinant in the heterozygote, but do suggest that it is absent in cis within the limits of this relatively small all types; two subjects were also heterozygous I Was also heterozygous for Hb-E. § See (6). I i See (7, 8) . ¶ See (9); two subjects were also heterozygous for Hb-S. The T-chain in f3thalassemia and 8,3thalassemia.
The data of (Fig. 2) . Family C. Hematological data about this family have been reported by Friedman et al. (10) . Fig. 3 presents the relevant part ofthe pedigree with quantitative data of several types. The propositus, 111-7, is homozygous for 8-thalassemia and is at least heterozygous for the 8+-type. In addition, he has both Hb-A2 and Hb-A'. In the mother, her sister, and two siblings of the propositus, Hb-A2 is in cis to the f8-thalassemia determinant, whereas the father and one sibling have Hb-A2 in cis to the f3-thalassemia determinant.
The data show that Ty-chain is not produced in cis to ,B- Frequency his father could be accurately determined; however, that in the sibling III-6 was somewhat high because of technical problems. These data indicate that the propositus who must be heterozygous for the Ty_ determinant had about one-half the percentage of Ty-chain found in the Hb-F of his father. Assuming that his Hb-F comes about equally from both maternal and paternal ,8-thalassemia determinants, Hb-F without T y chain from the maternal determinant has diluted the Hb-F with the Ty-chain from the paternal determinant.
In the Chinese Family W., the daughter II-1, who is heterozygous for 13-thalassemia, inherited the Ty-determinant from her mother and not from her father (Fig.  4) . The sibling II-2, who is homozygous for 8-thalassemia, is also heterozygous for the Ty-determinant. The 70% Ty-chains in the Hb-F of II-1 and one-halfthat percentage in II-2 suggest that, as in Family C., there is a dilution of Ty-chains in this 83-thalassemia homozygote. The expression of the Ty-chain in Family B. is also illustrated in Fig. 4 . Because homozygote 11-2 had no Hb-A at birth, nor did she produce any before her first transfusion at 112 d (11), ,o-thalassemia must be present. The percentages of Ty_chain in the father, the mother, and one older sister, who also had a thalassemia homozygozity, are rather similar; thus, one might conclude that there is no dilution effect in these homozygotes who are also homozygous for the Ty_chain.
The relationships in Family D., which have been described in other respects (12) , are given in Fig. 5 (Table VI) show that the Ty-chain gene may be present in trans, but that with the decrease in the activity of the Gy. and Ay_genes in trans, the relative production of the Ty-chain decreases accordingly to a level at which it will not be detectable any longer. The frequency of Ty-chain in Caucasian f8-thalassemia homozygotes (23 of 65 cases studied, which corresponds to a frequency of 0.18) is less than that reported by Ricco et al. ( 3) (39 of 42 cases studied, corresponding to a frequency of 0.46) and is not significantly different from that of newborn (Table II) . It appears desirable to analyze the Hb-F from newborn of different racial and ethnic backgrounds to evaluate the world-wide occurrence of the Ty-chain. The Ty-chain in relation to the Gy_ and Ay-chains. Because all samples of Hb-F have either Gy_ or Ay_ chains or both, that is, either glycine or alanine or both at position 136, it follows that the Ty_chain must have one or both. Ricco et al. (3) concluded from indirect evidence that the Ty-chain "certainly has glycine in position 136" and might also have alanine. In their investigation of Hb-F-Sardinia (which is another example of the Ty-chain in a thalassemia individual), Grifoni et al. (13) came to the same conclusion. However, when in previous studies the fraction of Tyy-chain was plotted against the fraction of y-chains that are Gy_ chains, a rather ill-defined inverse correlation appeared to exist (4); conversely, this would indicate a direct correlation with the fraction of Ay-chains in Hb-F. Such a plot, however, is too simple and ignores completely the source of Hb-F and the possibility that the Ty_chain gene is in cis or in trans (or both) of the primary genetic determinant of the condition involved. The data given in Fig. 6 Glycine in yCB-3 FIGURE 6 Relationship between the percentage of Ty-chain and the fraction of Some of the available data of Fig. 6 are difficult to explain because it cannot be determined with certainty into which category they belong. It is noteworthy, however, that the three ,B-thalassemia homozygotes of Fig. 4 fall in the expected categories, namely II-2 of Family W. with a Ty-chain heterozygosity in the category of decreased percent Ty_chain, and cases 11-1 and 11-2 with a Ty-chain-homozygosity in the category in which the correlation between the percentage of Ty-and Ay-chain is clearly evident. Fig. 7 gives similar data for individuals without hemoglobinopathies, and, although the data scatter considerably, an inverse correlation between the percentages of Ty-and Gy_chains appears to exist. A comparison of these data with those of Fig. 6 suggests that all persons are heterozygous for the Ty_chain.
Thus, the data demonstrate a distinct inverse relationship between the Ty-and the Gy_chains: as the Gyy-chain decreases in a sample, the Ty_chain increases. We conclude, therefore, that the Ty-chain is an Ay-chain: that is, has an alanyl residue in position 136 and should be designated TAy_chain. This conclusion is given support by the fact that none ofthe samples of Hb-F that has exclusively Gy_chains also has Ty_chains. It is also supported by the cord-blood data because the value of 31% Ty-chain in the four presumed homozygotes correlates well with the 29% A y-chain found in newborn babies (5) . Furthermore, the data listed in Table VI show that in this baby, who is positive for the Ty-chain and heterozygous for the Gy-HPFH condition, the production of both the Ay-chain and the Ty-chain decreases simultaneously and to the same extent.
Recent studies of the fetal hemoglobins of five orangutans have shown that each of these samples have a Vy-chain, i.e., a chain with a valyl residue in position 75, in addition to the 'y-chain which has an isoleucyl residue in position 75 (14) . This heterogeneity is in addition to the one in position 135 which is occupied by either a threonyl residue (the Tyy-chain) or an alanyl residue (the Ay-chain) (15) . The present information suggests that Ile-75 and Thr-135 are in one chain (the IT y-chain) and Val-75 and Ala-135 in the other chain (the VAyy-chain). Thus, this type of heterogeneity is similar to that of the human fetal hemoglobins, although the incidence of the human TAy-chain appears to be considerably less than that of the VAy-chain of the orangutan.
Some genetic considerations. Is the human TAy_ gene that produces the TAy_chain a mutant of the "normal" Ay-gene or genes, or is it a duplication? We have presented evidence (16, 17) 
